We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.
Teva UK Ltd. has informed the MHRA of a labelling error. This notification provides further advice on the safe use of the product.
medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to pink discolouration of the dacarbazine solution immediately after reconstitution (after correct preparation and storage).
medac GmbH (t/a medac Pharma LLP) is recalling further batches due to particles detected during long-term stability tests.
Product Safety Report for Esapharma Movate Steroid Cream presenting a serious chemical risk.
Recommendations for a temporary class drug order on a number of methylphenidate-based novel psychoactive substances.
Guidance for prescribing vets on the use of the cascade.
New proof-of-concept tool uses crime data to provide an early warning of potential problems, enabling quicker action from inspectors.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
VICH consultation until 15 August 2024 on guidelines relating to the technical requirements for demonstrating pharmaceutical development of veterinary medicinal products.
Calculate nutrient budgets for developments in the catchment of Solent.
Resources for the management of chemical, radiation and biological incidents, including UK recovery handbooks.
This Guide examines the effectiveness of team-based care in improving blood pressure outcomes
Product Recall for SMART electric height-adjustable mobile stand presenting a risk of injuries.
Annual statistics on the strength of Ministry of Defence sponsored cadet forces.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.